MedPath

Neuralace Medical, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy

Completed
Conditions
Chemotherapy-induced Peripheral Neuropathy
Neuropathic Pain
Neuralgia
First Posted Date
2023-07-07
Last Posted Date
2024-07-11
Lead Sponsor
NeuraLace Medical, Inc.
Target Recruit Count
14
Registration Number
NCT05935956
Locations
🇺🇸

Carolinas Pain Institute and Center for Clinical Research, Winston-Salem, North Carolina, United States

Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medical Management

Not Applicable
Completed
Conditions
Neuropathic Pain
Painful Diabetic Neuropathy
Neuralgia
Interventions
Device: Sham and CMM
Device: Axon Therapy and CMM
First Posted Date
2022-11-17
Last Posted Date
2024-07-11
Lead Sponsor
NeuraLace Medical, Inc.
Target Recruit Count
93
Registration Number
NCT05620225
Locations
🇺🇸

Centurion Spine and Pain Centers, Waycross, Georgia, United States

🇺🇸

Carolinas Pain Institute and Center for Clinical Research, Winston-Salem, North Carolina, United States

🇺🇸

Florida Pain Management Associates, P.A., Vero Beach, Florida, United States

and more 2 locations

Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management

Not Applicable
Active, not recruiting
Conditions
Neuropathic Pain
Peripheral Neuropathy
Interventions
Device: CMM + Axon Therapy
First Posted Date
2021-03-12
Last Posted Date
2024-07-12
Lead Sponsor
NeuraLace Medical, Inc.
Target Recruit Count
61
Registration Number
NCT04795635
Locations
🇺🇸

National Spine and Pain Centers, Shrewsbury, New Jersey, United States

🇺🇸

SC Pain and Spine Specialists (Crescent Moon Research Corp), Murrells Inlet, South Carolina, United States

🇺🇸

Carolinas Pain Institute, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath